Naomi Biswas is a biotechnology intellectual property attorney with 25 years of experience in patent and trademark portfolio management. Naomi’s background as both in-house counsel and private practice attorney enables her to provide strategic, business-focused counseling in all areas of her practice, including infringement analysis, portfolio development, licensing negotiation and transaction-related due diligence. Her areas of expertise include genomics and post-genomics technologies, antibody engineering, small-molecule, biological, and nucleotide based therapeutics and a broad array of therapeutic areas including oncology, cardiovascular disease, metabolic disease, and CNS disorders. She has also advised clients in the chemical industry.
Previously, Naomi was a partner in the intellectual property group of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo. At Mintz, Naomi advised a broad array of clients, including start-up companies, universities, research foundations, and multinational corporations, on patent prosecution and management strategies, and offered due diligence support.
Prior to Mintz, Naomi served as Director of Intellectual Property at Centeon (now CSL Behring), a multinational pharmaceutical company specializing in blood plasma products and biologics. As their lead US patent attorney, Naomi oversaw the prosecution and management of CSL Behring’s international patent portfolio. She also worked closely with the senior management team to develop and implement patent strategies and manage all IP-related due diligence for licensing transactions, financings, and potential mergers and acquisitions. Naomi began her legal career as an attorney at Synnestvedt & Lechner, a boutique intellectual property firm in Philadelphia.
Naomi received an AB in Molecular Biology from Princeton University and a JD from the University of Pennsylvania Law School where she was on law review.
Outside the office, Naomi is an avid tennis fan, and enjoys both playing and watching her children compete in college tennis matches.